JD.Com Inc’s JD healthcare subsidiary JD Health International Inc could be valued between $25.3 billion and $28.5 billion in its Hong Kong initial public offering, Bloomberg reports.
What Happened: With approximately 381.9 million share issues in a price range of HKD 62.8 and HKD 70.58, the Hong Kong listing is expected to generate between $3 billion and $3.5 billion in proceeds.
The pricing details could be out on Dec. 1 with the trading debut commencing a week later on Dec. 8.
Singapore Sovereign Wealth Fund GIC Pte Ltd., Hillhouse Capital Advisors Limited, BlackRock Inc BLK, and three other investors have agreed to subscribe for close to $1.35 billion worth of JD Health’s stock, as per Bloomberg.
Why Does It Matter: JD Health is on track to set a record for the largest healthcare sector IPO in Asia. It could overtake Japanese pharma company Otsuka Holdings Co OTSKY, which has held the record for almost a decade with its $2.3 billion IPO in 2010.
In June, parent company JD.com too opted for a secondary listing, which turned out to be Hong Kong’s largest first-time shares sale of 2020.
Price Action: JD shares closed at $89.82, 2.58% higher, on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
